INVESTOR RELATIONSall about redsense blood loss detection

patrik byhmer
Patrik Byhmer 
CEO (Born 1966) CEO and founder.
 
Bachelor of Behavioral Sciences at Lund University, Master of Science in Engineering Physics at Lund Faculty of Engineering, Reserve Officer at Infantry Officer College in Halmstad. Byhmer has extensive experience leading global businesses, managing staff, distribution networks, agents and production outside Europe. Byhmer has worked in marketing at Procter & Gamble, has been BU director for medical technology companies with global distribution (Etac AB), has set up new technology business operations in mobile technology (global V.P. Sales & Marketing gigaAnt, Perlos (present Lite-On), Ante Nova). Patrik Byhmer owns 1,700,581 shares in Redsense Medical both privately and via company.
 
 
brendan kane1
Brendan Kane 
U.S. Director of Sales
 
Brendan joined Redsense Medical as U.S. Director of Sales in January 2016. He has 25 plus years of renal industry experience. Brendan has held various sales, sales management, and business development positions with National Medical Care, Fresenius Medical Care, American Renal Associates and other renal equipment and pharmaceutical manufacturers. In this new position Brendan will develop customer relations, manage all U.S. sales, and assist in corporate marketing operations. He received his B. S. Degree in Marketing from Stonehill College in Easton, MA.
 
 
Jane Hurst 1
Jane Hurst 
Product Management Director, Redsense Medical Inc (USA).

 

Hurst started her career as a nurse in 1980. Her experience covers a wide range of medical specialties including nephrology, hemodialysis, burns and oncology. In 2002, Hurst obtained a certification to consult in nursing issues in the judiciary. Hurst provides medical-legal knowledge to prosecutors, insurance companies, businesses and governments. In addition to her work as a consultant in the legal-medical issues, Hurst teaches in a national (USA) certification program for consultants in legal-medical issues and is a mentor to other legal-medical consultants. Jane Hurst owns 105 000 shares in Redsense Medical.